1. Potential for reducing immobility times of a mobility monitor in-bed sensor system – a stepped-wedge cluster-randomised trial
- Author
-
Sven Ziegler, Claudia Schmoor, Lili M. Schöler, Sam Schepputat, Eyere Takem, Birgit Grotejohann, Inga Steinbrenner, and Johanna Feuchtinger
- Subjects
Digital technology ,In-bed sensor ,Mobility monitoring ,Nursing ,Pressure Ulcer ,Repositioning ,RT1-120 - Abstract
Abstract Background Pressure ulcer prophylaxis is a central topic in clinical care. Pressure-relieving repositioning is strongly recommended for all pressure-sensitive patients. The Mobility Monitor (MoMo) is a technical device that records a patient’s movements and transmits the data to a monitor. This study investigated the extent to which the MoMo sensor system, which records and visualises patients’ movements in bed, supports nurses in performing pressure-relieving repositioning in neurological and neurosurgical intensive care units (ICU). Methods This stepped-wedge cluster-randomised trial involved two clusters: one neurological and one neurosurgical ICU. The study was carried out in two steps over three periods between November 2018 and May 2019, with a two-month interval between each step. At the beginning of the study, we equipped 33 beds across the two ICUs with a MoMo system. Our primary endpoint was the immobility rate, which is defined as the patient’s inactive time in bed exceeding two hours without pressure-relieving movements divided by the time the MoMo was in the bed. The immobility rate ranges from 0 to below 1, with higher values indicating lower mobility. Secondary endpoints were the rate of new pressure ulcers and the rate of relevant pressure-relieving repositionings. Relevant repositionings are defined as the number of repositionings identified by the MoMo as a pressure-relieving repositioning divided by the total number of repositionings, Results 808 patients were included in the study, of whom 403 were in the control group and 405 were in the intervention group. The mean immobility rate was 0.171 during the control phase and 0.144 during the intervention phase. The estimated intervention effect was -0.0018 (95% confidence interval [-0.0471, 0.0436], p=0.94). The number of new pressure ulcers was 5/405 in the intervention phase and 15/403 in the control phase. We noted a small difference in the mean rate of relevant repositioningswith an estimated intervention effect of 0.046 (95% confidence interval [-0.018, 0.110], p=0.16). Conclusion Our results are insufficient to recommend the standardised use of mobility monitors in neurological or neurosurgical ICUs. Clinical trial registration The primary analysis was prespecified and the trial was registered in the German Clinical Trials Register (DRKS) under the reference number DRKS00015492 (31/10/2018).
- Published
- 2023
- Full Text
- View/download PDF